Pharma
Global Pharmaceutical Intermediates Market Opportunities and Forecast 2020-2027
  • DLR481
  • 19 March, 2022
  • Pharma & Healthcare
  • Pages: 120
  • Global
Global Pharmaceutical Intermediates Market, By Product (Bulk Drug Intermediate, Custom Intermediate) By Application (Cardiology, Oncology, Endocrinology, Infectious Diseases, Orthopedics, Neurology, Gastroenterology, Dermatology, Inflammatory & Pain Management, Ophthalmology, and Others) By End User (Pharmaceutical & Biotechnology Companies, CROs & CMOs), and opportunities and forecast 2020-2027

Pharmaceutical Intermediates Market Overview

Pharmaceutical intermediates are medications that are utilized as raw materials in the manufacture of bulk pharmaceuticals. Furthermore, they are frequently used to describe a material formed during the synthesis of an active pharmaceutical ingredient (API) before it is processed into an API. The global Pharmaceutical Intermediates market is projected to grow at a considerable rate in the coming years.
 
Every year, the world is experiencing an increase in the number of diseases and patients. Furthermore, the number of physician consultations for infectious and parasitic disorders has soared into the millions, resulting in a surge in demand for a variety of pharmaceuticals. High R&D spending and developments in breakthrough therapeutics are expected to boost the pharmaceutical intermediates market's growth pace in the near future. Furthermore, the growing demand for research and development across the world is escalating the growth of the global pharmaceutical intermediates market in the forecast period. The global pharmaceutical intermediates market is predicted to increase in the near future due to the deployment of standardized pharmaceutical activities and good manufacturing standards (GMP) in pharmaceutical businesses.
 
On the downside, strict regulatory policies for manufacturers for product quality will hamper the growth of the global Pharmaceutical Intermediates market. However, with an increase in healthcare expenditure, the global pharmaceutical intermediates market is projected to expand at a higher rate in the forthcoming years.
 
Report Metric Details
Market size available for years 2019–2027
Base year considered 2019
Forecast period 2020–2027
Forecast unit Value (USD Million)
Segments covered Product, Application, End User, and Region
Regions covered North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA)
Companies covered BASF SE, Lonza Group, Evonik Industries AG, Cambrex Corporation, DSM, Aceto, Albemarle Corporation, Vertellus, Chemcon Speciality Chemicals Ltd., chiracon GmbH, A. R. Life Sciences Private Limited.


Covid-19 Impact on Pharmaceutical Intermediates Market
 
In addition, the current Pharmaceutical Intermediates Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Pharmaceutical Intermediates Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long-term as well as short-term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.

Pharmaceutical Intermediates Market Segment Overview



According to End User, the Pharmaceutical & Biotechnology Companies is one of the largest segments in the global Pharmaceutical Intermediates market. The majority of pharmaceutical intermediates are made from high-quality basic materials. In the pharmaceutical and cosmetic sectors, these intermediates are commonly employed. The global pharmaceu5tical intermediates market is developing due to rising demand in these industries. Furthermore, the international chemical industry has seen a significant increase in the manufacturing of pharmaceutical intermediates. The global need for pharmaceutical intermediates is being driven by the increasing chemical industry. Pharmaceutical intermediates are made to order for bulk and specialized manufacturing.
 
Pharmaceutical Intermediates Market, By Product
  • Bulk Drug Intermediate
    • Chiral Intermediate
    • Achiral Intermediate
  • Custom Intermediate
Pharmaceutical Intermediates Market, By Application
·       Cardiology
·       Oncology
·       Endocrinology
·       Infectious Diseases
·       Orthopedics
·       Neurology
·       Gastroenterology
·       Dermatology
·       Inflammatory & Pain Management
·       Ophthalmology
·       Others

Pharmaceutical Intermediates Market, By End User
·       Pharmaceutical & Biotechnology Companies
·       CROs & CMOs

Pharmaceutical Intermediates Regional Overview

Region-Wise, North America is expected to hold a maximum share of the pharmaceutical intermediate market. This is mainly because of the growing pharmaceutical manufacturers and consumers in the U.S. and Canada. Furthermore, the rising prevalence of many contagious and chronic diseases has increased demand for pharmaceuticals, which is expected to propel the pharmaceutical intermediates market forward throughout the forecast period. Furthermore, the presence of significant industry players in North America is aiding the growth of the pharmaceutical intermediates market in the region. Moreover, Europe is another major region for the market. Increased demand for enhanced pharmaceutical products is expected to rise market growth during the projected period in this region.

Pharmaceutical Intermediates Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
 
Pharmaceutical Intermediates Market Competitor overview

Some key developments and strategies adopted by manufacturers in Pharmaceutical Intermediates are highlighted below.

·       Carlyle commenced its partnership with Viyash in June 2021, when the company acquired a controlling stake in Symed Labs, a leading manufacturer of niche APIs to enable backward integration. Viyash has also acquired a controlling stake in Appco Pharma LLC, US, a formulations player focused on the US market which will help expand access to US generics market and formulation capabilities.

·       In November 2021, Global pharmaceutical industry supplier ACG recently announced its plans to invest INR 6 billion (US$80.56 million) to build Asia’s largest capsule manufacturing unit in India. This facility will augment India’s industrial capacity to provide high quality, safe, and affordable medicines and nutraceuticals globally. ACG was founded in Mumbai in 1961 and is now present worldwide, providing integrated solutions for the pharmaceutical and nutraceutical industries.

Pharmaceutical Intermediates Market, Key Players

·       BASF SE
·       Lonza Group
·       Evonik Industries AG
·       Cambrex Corporation
·       DSM
·       Aceto
·       Albemarle Corporation
·       Vertellus
·       Chemcon Speciality Chemicals Ltd.
·       chiracon GmbH
·       R. Life Sciences Private Limited

Frequently Asked Questions (FAQ) :

Q1. What are the driving factors for the Pharmaceutical Intermediates market?

A. High R&D spending and developments in breakthrough therapeutics are expected to boost the pharmaceutical intermediates market's growth pace in the near future

Q2. What are the restraining factors for the Pharmaceutical Intermediates market?

A. Strict regulatory policies for manufacturers for product quality will hamper the growth of the global Pharmaceutical Intermediates market

Q3. Which segment is projected to hold the largest share in the Pharmaceutical Intermediates Market?

A. Pharmaceutical & Biotechnology Companies segment is projected to hold the largest share in the Pharmaceutical Intermediates Market

Q4. Which region holds the largest share in the Pharmaceutical Intermediates market?

A. North America held the largest share in the global Pharmaceutical Intermediates market

Q5. Which are the prominent players in the Pharmaceutical Intermediates Market?

A. BASF SE, Lonza Group, Evonik Industries AG, Cambrex Corporation, DSM, Aceto, Albemarle Corporation, Vertellus, Chemcon Speciality Chemicals Ltd., chiracon GmbH, A. R. Life Sciences Private Limited. are some key players in the Pharmaceutical Intermediates Market.
Pharmaceutical Intermediates Market Study Global Market Analysis, Insights and Forecast, 2020-2027

    1. Introduction

    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions

    2. Executive Summary

      3. Market Dynamics

      • 3.1. Market Drivers
      • 3.2. Market Restraints
      • 3.3. Market Opportunities

      4. Key Insights

      • 4.1. Key Emerging Trends – For Major Countries
      • 4.2. Latest Technological Advancement
      • 4.3. Regulatory Landscape
      • 4.4. Industry SWOT Analysis
      • 4.5. Porters Five Forces Analysis

      5. Global Pharmaceutical Intermediates Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 5.1. Key Findings / Summary
      • 5.2. Market Analysis, Insights and Forecast – By Product
        • 5.2.1. Bulk Drug Intermediate
          • 5.2.1.1. Chiral Intermediate
          • 5.2.1.2. Achiral Intermediate
        • 5.2.2. Custom Intermediate
      • 5.3. Market Analysis, Insights and Forecast – By Application
        • 5.3.1. Cardiology
        • 5.3.2. Oncology
        • 5.3.3. Endocrinology
        • 5.3.4. Infectious Diseases
        • 5.3.5. Orthopedics
        • 5.3.6. Neurology
        • 5.3.7. Gastroenterology
        • 5.3.8. Dermatology
        • 5.3.9. Inflammatory & Pain Management
        • 5.3.10. Ophthalmology
        • 5.3.11. Others
      • 5.4. Market Analysis, Insights and Forecast – By End User
        • 5.4.1. Pharmaceutical & Biotechnology Companies
        • 5.4.2. CROs & CMOs
      • 5.5. Market Analysis, Insights and Forecast – By Region
        • 5.5.1. North America
        • 5.5.2. Europe
        • 5.5.3. Asia Pacific
        • 5.5.4. Latin America, Middle East and Africa

      6. North America Pharmaceutical Intermediates Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 6.1. Key Findings / Summary
      • 6.2. Market Analysis, Insights and Forecast – By Product
        • 6.2.1. Bulk Drug Intermediate
          • 6.2.1.1. Chiral Intermediate
          • 6.2.1.2. Achiral Intermediate
        • 6.2.2. Custom Intermediate
      • 6.3. Market Analysis, Insights and Forecast – By Application
        • 6.3.1. Cardiology
        • 6.3.2. Oncology
        • 6.3.3. Endocrinology
        • 6.3.4. Infectious Diseases
        • 6.3.5. Orthopedics
        • 6.3.6. Neurology
        • 6.3.7. Gastroenterology
        • 6.3.8. Dermatology
        • 6.3.9. Inflammatory & Pain Management
        • 6.3.10. Ophthalmology
        • 6.3.11. Others
      • 6.4. Market Analysis, Insights and Forecast – By End User
        • 6.4.1. Pharmaceutical & Biotechnology Companies
        • 6.4.2. CROs & CMOs
      • 6.5. Market Analysis, Insights and Forecast – By Country
        • 6.5.1. U.S.
        • 6.5.2. Canada

      7. Europe Pharmaceutical Intermediates Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Product
        • 7.2.1. Bulk Drug Intermediate
          • 7.2.1.1. Chiral Intermediate
          • 7.2.1.2. Achiral Intermediate
        • 7.2.2. Custom Intermediate
      • 7.3. Market Analysis, Insights and Forecast – By Application
        • 7.3.1. Cardiology
        • 7.3.2. Oncology
        • 7.3.3. Endocrinology
        • 7.3.4. Infectious Diseases
        • 7.3.5. Orthopedics
        • 7.3.6. Neurology
        • 7.3.7. Gastroenterology
        • 7.3.8. Dermatology
        • 7.3.9. Inflammatory & Pain Management
        • 7.3.10. Ophthalmology
        • 7.3.11. Others
      • 7.4. Market Analysis, Insights and Forecast – By End User
        • 7.4.1. Pharmaceutical & Biotechnology Companies
        • 7.4.2. CROs & CMOs
      • 7.5. Market Analysis, Insights and Forecast – By Country
        • 7.5.1. UK
        • 7.5.2. Germany
        • 7.5.3. France
        • 7.5.4. Italy
        • 7.5.5. Spain
        • 7.5.6. Russia
        • 7.5.7. Rest of Europe

      8. Asia Pacific Pharmaceutical Intermediates Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Product
        • 8.2.1. Bulk Drug Intermediate
          • 8.2.1.1. Chiral Intermediate
          • 8.2.1.2. Achiral Intermediate
        • 8.2.2. Custom Intermediate
      • 8.3. Market Analysis, Insights and Forecast – By Application
        • 8.3.1. Cardiology
        • 8.3.2. Oncology
        • 8.3.3. Endocrinology
        • 8.3.4. Infectious Diseases
        • 8.3.5. Orthopedics
        • 8.3.6. Neurology
        • 8.3.7. Gastroenterology
        • 8.3.8. Dermatology
        • 8.3.9. Inflammatory & Pain Management
        • 8.3.10. Ophthalmology
        • 8.3.11. Others
      • 8.4. Market Analysis, Insights and Forecast – By End User
        • 8.4.1. Pharmaceutical & Biotechnology Companies
        • 8.4.2. CROs & CMOs
      • 8.5. Market Analysis, Insights and Forecast – By Country
        • 8.5.1. China
        • 8.5.2. India
        • 8.5.3. Japan
        • 8.5.4. Australia
        • 8.5.5. South East Asia
        • 8.5.6. Rest of Asia Pacific

      9. Latin America, Middle East and Africa Pharmaceutical Intermediates Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 9.1. Key Findings / Summary
      • 9.2. Market Analysis, Insights and Forecast – By Product
        • 9.2.1. Bulk Drug Intermediate
          • 9.2.1.1. Chiral Intermediate
          • 9.2.1.2. Achiral Intermediate
        • 9.2.2. Custom Intermediate
      • 9.3. Market Analysis, Insights and Forecast – By Application
        • 9.3.1. Cardiology
        • 9.3.2. Oncology
        • 9.3.3. Endocrinology
        • 9.3.4. Infectious Diseases
        • 9.3.5. Orthopedics
        • 9.3.6. Neurology
        • 9.3.7. Gastroenterology
        • 9.3.8. Dermatology
        • 9.3.9. Inflammatory & Pain Management
        • 9.3.10. Ophthalmology
        • 9.3.11. Others
      • 9.4. Market Analysis, Insights and Forecast – By End User
        • 9.4.1. Pharmaceutical & Biotechnology Companies
        • 9.4.2. CROs & CMOs
      • 9.5. Market Analysis, Insights and Forecast – By Country
        • 9.5.1. Brazil
        • 9.5.2. Saudi Arabia
        • 9.5.3. UAE
        • 9.5.4. Rest of LAMEA

      10. Competitive Analysis

      • 10.1. Company Market Share Analysis, 2018
      • 10.2. Key Industry Developments
      • 10.3. Company Profile
      • 10.4. BASF SE
        • 10.4.1. Business Overview
        • 10.4.2. Segment 1 & Service Offering
        • 10.4.3. Overall Revenue
        • 10.4.4. Geographic Presence
        • 10.4.5. Recent Development
      *Similar details will be provided for the following companies
      • 10.5. Lonza Group
      • 10.6. Evonik Industries AG
      • 10.7. Cambrex Corporation
      • 10.8. DSM
      • 10.9. Aceto
      • 10.10. Albemarle Corporation
      • 10.11. Vertellus
      • 10.12. Chemcon Speciality Chemicals Ltd.
      • 10.13. chiracon GmbH
      List of Figures

      Figure 1: Global Pharmaceutical Intermediates Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
      Figure 2: Global Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 3: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 4: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 5: Global Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 6: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 7: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 8: Global Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 9: Global Pharmaceutical Intermediates Market Forecast (USD Billion), by Others, 2016-2027
      Figure 10: Global Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 11: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 12: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 13: Global Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 14: Global Market Forecast (USD Billion), by Others, 2016-2027
      Figure 15: Global Market Value (USD Billion), by Region, 2019 & 2027
      Figure 16: North America Pharmaceutical Intermediates Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 17: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 18: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 19: North America Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 20: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 21: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 22: North America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 23: North America Market Forecast (USD Billion), by Others, 2016-2027
      Figure 24: North America Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 25: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 26: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 27: North America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 28: North America Market Forecast (USD Billion), by Others, 2016-2027
      Figure 29: North America Market Forecast (USD Billion), by U.S., 2016-2027
      Figure 30: North America Market Forecast (USD Billion), by Canada, 2016-2027
      Figure 31: Latin America Pharmaceutical Intermediates Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 32: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 33: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 34: Latin America Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 35: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 36: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 37: Latin America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 38: Latin America Market Forecast (USD Billion), by Others, 2016-2027
      Figure 39: Latin America Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 40: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 41: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 42: Latin America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 43: Latin America Market Forecast (USD Billion), by Others, 2016-2027
      Figure 44: Latin America Market Forecast (USD Billion), by Brazil, 2016-2027
      Figure 45: Latin America Market Forecast (USD Billion), by Mexico, 2016-2027
      Figure 46: Latin America Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
      Figure 47: Europe Pharmaceutical Intermediates Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 48: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 49: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 50: Europe Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 51: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 52: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 53: Europe Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 54: Europe Market Forecast (USD Billion), by Others, 2016-2027
      Figure 55: Europe Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 56: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 57: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 58: Europe Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 59: Europe Market Forecast (USD Billion), by Others, 2016-2027
      Figure 60: Europe Market Forecast (USD Billion), by U.K., 2016-2027
      Figure 61: Europe Market Forecast (USD Billion), by Germany, 2016-2027
      Figure 62: Europe Market Forecast (USD Billion), by France, 2016-2027
      Figure 63: Europe Market Forecast (USD Billion), by Italy, 2016-2027
      Figure 64: Europe Market Forecast (USD Billion), by Spain, 2016-2027
      Figure 65: Europe Market Forecast (USD Billion), by Russia, 2016-2027
      Figure 66: Europe Market Forecast (USD Billion), by Rest of Europe, 2016-2027
      Figure 67: Asia Pacific Pharmaceutical Intermediates Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 68: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 69: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 70: Asia Pacific Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 71: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 72: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 73: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 74: Asia Pacific Market Forecast (USD Billion), by Others, 2016-2027
      Figure 75: Asia Pacific Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 76: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 77: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 78: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 79: Asia Pacific Market Forecast (USD Billion), by Others, 2016-2027
      Figure 80: Asia Pacific Market Forecast (USD Billion), by China, 2016-2027
      Figure 81: Asia Pacific Market Forecast (USD Billion), by India, 2016-2027
      Figure 82: Asia Pacific Market Forecast (USD Billion), by Japan, 2016-2027
      Figure 83: Asia Pacific Market Forecast (USD Billion), by Australia, 2016-2027
      Figure 84: Asia Pacific Market Forecast (USD Billion), by Southeast Asia, 2016-2027
      Figure 85: Asia Pacific Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
      Figure 86: Middle East & Africa Pharmaceutical Intermediates Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 87: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 88: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 89: Middle East & Africa Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 90: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 91: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 92: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 93: Middle East & Africa Market Forecast (USD Billion), by Others, 2016-2027
      Figure 94: Middle East & Africa Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 95: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 96: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 97: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 98: Middle East & Africa Market Forecast (USD Billion), by Others, 2016-2027
      Figure 99: Middle East & Africa Market Forecast (USD Billion), by GCC, 2016-2027
      Figure 100: Middle East & Africa Market Forecast (USD Billion), by South Africa, 2016-2027
      Figure 101: Middle East & Africa Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027 
      List of Tables
      Table 1: Global Pharmaceutical Intermediates Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 2: Global Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 3: Global Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 4: Global Market Revenue (USD Billion) Forecast, by Region, 2016-2027
      Table 5: North America Pharmaceutical Intermediates Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 6: North America Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 7: North America Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 8: North America Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 9: Europe Pharmaceutical Intermediates Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 10: Europe Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 11: Europe Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 12: Europe Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 13: Latin America Pharmaceutical Intermediates Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 14: Latin America Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 15: Latin America Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 16: Latin America Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 17: Asia Pacific Pharmaceutical Intermediates Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 18: Asia Pacific Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 19: Asia Pacific Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 20: Asia Pacific Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 21: Middle East & Africa Pharmaceutical Intermediates Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 22: Middle East & Africa Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 23: Middle East & Africa Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 24: Middle East & Africa Market Revenue (USD Billion) Forecast, by Country, 2016-2027

      Report You Might be Interested

      Choose License Type

      • USD
      • GBP
      • EURO
      • INR
      Credit card Logo

      Happy To Assist You

      Have a Question? email us at

      [email protected]

      Or Call Us On

      US +1 360 851 1343

      IND +91 880 579 4934